Breakthrough Microcurrent Technology Product Procellera® Featured in Eight Scientific and Clinical Abstracts at SAWC May 2 - 5 EVIDENCE-BASED CLINICAL OUTCOMES ESTABLISHED IN PROCELLERA® WOUND CARE STUDIES
CHANDLER, Ariz., May 1, 2013 /PRNewswire/ -- Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced that eight scientific and clinical abstracts on its flagship product Procellera® will be presented at the 26th Annual Symposium on Advanced Wound Care (SAWC) May 2 - 5, 2013 at the Denver Convention Center.
Procellera® is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Indications for use include partial and full-thickness wounds such as pressure ulcers, venous ulcers, diabetic ulcers, burns, surgical incisions, donor and/or recipient graft sites.
"This robust collection of high-level scientific and clinical research from some of the best institutions around the country marks the achievement of a significant milestone for Procellera®," said Michael P. Nagel, Vomaris President and CEO. "We are thrilled to give the marketplace the evidence-based clinical outcomes needed to support wider use of our breakthrough product."
One of the abstracts - "Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing" by lead author Dr. Chandan Sen of Ohio State University - was selected along with three other abstracts as finalists in Excellence in Translational Regenerative Science, honoring investigators involved in cutting edge research fostering the development of cell-based and other therapies in wound healing and regenerative medicine toward clinical applicability. Dr. Sen will give a podium presentation at Session G on May 2, from 9:00 - 9:45am.
Two abstracts, "Evaluation of a Bioelectric Dressing as the Next Generation Wound Care Product in the Battlefield" and "Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Isolates" feature collaborative translational and laboratory research from Diagnostic & Translational Research Center, Walter Reed National Military Medical Center, Henry M. Jackson Foundation and the Combat Wound Initiative.
The remaining five abstracts feature a range of clinical research and case studies, including: "A Study to Demonstrate Efficacy of a Bioelectric Wound Care Dressing in Healing of Acute and Chronic Wounds within a Rehab Center Patient Population" and "Management of Traumatic Wounds with a Bioelectric Wound Dressing" from Bethany Health & Rehabilitation Center in Nashville, TN; "An Innovative Bioelectric Approach to Recalcitrant Wounds" and "Clinical Experience with a Bioelectric Wound Dressing as a Primary and Adjunctive Treatment Method" from Jackson-Madison County General Hospital in Jackson, TN; and "Improved Healing Outcomes with a Bioelectric Wound Dressing" from Grant Wound Care & Hyperbaric Services in Columbus, OH.
The SAWC is the largest annual gathering of scientists and clinicians in the wound care field in the United States and is a platform for linking scientists and clinicians to advance wound-healing research.
Procellera® will be showcased at booth #1035 at the SAWC.
About Vomaris Wound Care, Inc.
Vomaris Innovations, Inc., based in Chandler, Arizona, is a leading edge regenerative medical device company specializing in microcurrent field generating technologies for the wound care market. Its product, Procellera®, is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Procellera® is a unique device due to its inherent design with microcurrent technology. Procellera® is indicated for over-the-counter (OTC) and professional (Rx) uses. Randomized clinical trials are in process looking at other possible wound healing benefits for the use of Procellera®.
For more information, visit http://www.vomaris.com or call 480.921.4948.
SOURCE Vomaris Innovations, Inc.